Adamis Pharmaceuticals reported 1.15M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Adma Biologics ADMA:US $ 29.1M 2.72M
Cara Therapeutics CARA:US $ 4.79M 3.97M
GlaxoSmithKline GSK:LN 9780M 253M
Glaxosmithkline GSK:US $ 9780M 253M
Merk MRK:US $ 15901M 2380M
Pfizer PFE:US $ 25661M 2026M
Redhill Biopharma RDHL:US $ 18.24M 3.84M